Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -All, -A24, -A31, and-A33)-positive patients with advanced cancer.

Bibliographic Information

Title
Phase-I clinical study of a personalized peptide vaccination available for six different HLA (HLA-A2, -A3, -All, -A24, -A31, and-A33)-positive patients with advanced cancer.
Author
Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000782048468743
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top